Pharma Phorum

JANUARY 12, 2023

Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca (AZ) and development partner Avillion, has been approved by the US Food and Drug Administration (FDA). Commenting on the approval, Bradley E.

FDA Approval 52

FDA Approval Allergies Trials Containment 52

XTalks

SEPTEMBER 6, 2022

On Friday, Azurity Pharmaceuticals announced that the US Food and Drug Administration (FDA) approved their innovative oral liquid formulation Konvomep (omeprazole and sodium bicarbonate for oral suspension).

FDA Approval 83

FDA Approval Pharmacy Containment Doctors 83

XTalks

OCTOBER 18, 2022

Global medical device company Nevro Corp has received US Food and Drug Administration (FDA) approval for the Senza HFX iQ spinal cord stimulation (SCS) system for the treatment of long-term or chronic pain. It is also pursuing a CE mark approval of the spinal cord stimulator in Europe.

FDA Approval 82

FDA Approval Big Data Containment Life Science 82

XTalks

JANUARY 18, 2023

Ayesha also talked about the FDA approval of AstraZeneca’s asthma inhaler Airsupra, the first-in-class drug that contains both a beta agonist and corticosteroid. AstraZeneca’s Airsupra Approved as First-In-Class Combo Asthma Treatment.

Life Science 52

Life Science FDA Approval Containment Scientist 52

XTalks

OCTOBER 14, 2022

This week, GSK announced in a press release that the US Food and Drug Administration (FDA) had approved Boostrix as an immunization for pregnant women for the prevention of whooping cough in newborn infants. The evidence provided was sufficient to grant approval status.

FDA Approval 83

FDA Approval Bacteria Protein Containment 83

The Pharma Data

NOVEMBER 30, 2022

FDA Approves First Fecal Microbiota Product. Food and Drug Administration approved Rebyota, the first fecal microbiota product approved by the agency. Rebyota is approved for the prevention of recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older. Today’s approval of Rebyota is an advance in caring for patients who have recurrent C. director of the FDA’s Center for Biologics Evaluation and Research.

FDA Approval 62

FDA Approval Bacterium Production Containment 62

XTalks

DECEMBER 2, 2022

Swiss company Ferring Pharmaceuticals has won a historic approval from the US Food and Drug Administration (FDA) for its fecal transplant-based therapy Rebyota (fecal microbiota, live-jslm) to reduce the recurrence of bacterial infection.

FDA Approval 56

FDA Approval Bacteria Containment Clinical Trials 56

The Pharma Data

OCTOBER 21, 2022

RINVOQ is now approved as the first and only oral JAK inhibitor for adults with active non-radiographic axial spondyloarthritis (nr-axSpA) RINVOQ is the first and only JAK inhibitor approved for both active ankylosing spondylitis (AS) and nr-axSpA 1-3 In a clinical study, RINVOQ delivered rapid and meaningful disease control based on patients achieving ASAS40 vs. placebo, as well as significant improvement in signs and symptoms of nr-axSpA at week 14 1,2.

FDA Approval 63

FDA Approval Clinical Trials Clinical Trials Trials 63

XTalks

JANUARY 17, 2023

The US Food and Drug Administration (FDA) granted approval to AstraZeneca’s Airsupra (albuterol/budesonide), formerly known as PT027, for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of asthma attacks in individuals aged 18 years and older who have asthma.

Containment 82

Containment Allergies Drug Delivery FDA Approval 82

The Pharma Data

MAY 5, 2021

A weekly update on new drug approvals and indications from the US Food and Drug Administration (FDA). . New approvals. Hikma’s Kloxxado (naloxone hydrochloride nasal spray) has been approved for treating opioid overdose.

FDA Approval 52

FDA Approval Containment Antibody Production 52

XTalks

APRIL 23, 2021

GSK’s immunotherapy dostarlimab-gxly (Jemperli) has been granted accelerated approval by the US Food and Drug Administration (FDA) for the treatment of recurrent or advanced mismatch repair-deficient (dMMR) endometrial cancer.

FDA Approval 87

FDA Approval DNA Antibody Licensing 87

The Pharma Data

OCTOBER 10, 2022

US FDA approves BOOSTRIX for immunisation during gestation for the forestallment of whooping cough in invigorated babies. Roger Connor, President, Vaccines and Global Health, GSK, said “ We ’re immensely proud to have the first- ever Tdap vaccine approved by the FDA specifically for this use during gestation. The tip caps of the prefilled hypes for BOOSTRIX contain natural rubber latex, which may beget antipathetic responses.

Containment 63

Containment Vaccination Vaccine FDA Approval 63

XTalks

NOVEMBER 22, 2021

Virtual reality pain therapy company AppliedVR bagged de novo clearance from the US Food and Drug Administration (FDA) this week for its virtual reality EaseVRx system indicated as an adjunct treatment for chronic lower back pain for patients 18 years of age and older.

FDA Approval 52

FDA Approval Containment Clinical Trials Clinical Trials 52

Pharmacy Checkers

NOVEMBER 12, 2020

The new federal rule on drug importation from Canada , drafted pursuant to Section 804 of the FDCA, does not allow for the importation of foreign versions of FDA-approved drugs. It only allows for the importation of FDA-approved drugs.

Pharmacy 58

Pharmacy Filler FDA Approval Manufacturing 58

XTalks

DECEMBER 7, 2021

VBI Vaccines got its first vaccine approval from the US Food and Drug Administration (FDA) for its hepatitis B shot PreHevbrio. PreHevbrio is approved for the prevention of hepatitis B infection caused by the hepatitis B virus (HBV) in adults 18 years of age and older.

FDA Approval 86

FDA Approval Vaccination Vaccine Containment 86

The Pharma Data

NOVEMBER 27, 2020

FDA Approves Danyelza (naxitamab-gqgk) for the Treatment of Neuroblastoma. Food and Drug Administration (“FDA”) has approved Danyelza (naxitamab-gqgk) 40mg/10ml. The FDA granted approval under the accelerated approval regulation.

FDA Approval 52

FDA Approval Antibody Production Clinical Trials 52

Pharma Phorum

DECEMBER 4, 2020

Johnson & Johnson has filed its bispecific antibody amivantamab to the FDA, hoping to muscle into the big market for drugs that are used to treat EGFR-positive non-small cell lung cancer (NSCLC). The post J&J files lung cancer bispecific amivantamab for FDA approval appeared first on.

FDA Approval 71

FDA Approval Antibody Sales Licensing 71

The Pharma Data

OCTOBER 7, 2022

Food and Drug Administration approved Boostrix( Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine, Adsorbed( Tdap)) for immunization during the third trimester of gestation to help pertussis, generally known as whooping cough, in babies youngish than two months of age.

Cosmetics 82

Cosmetics FDA Approval Containment Antibody 82

The Pharma Data

AUGUST 31, 2021

Food and Drug Administration (FDA) has converted this indication from an accelerated to a full (regular) approval. 10), as determined by an FDA-approved test, or in patients who were not eligible for any platinum-containing chemotherapy regardless of PD-L1 status.

Containment 52

Containment FDA Approval Clinical Development Trials 52

XTalks

JANUARY 28, 2022

Kimmtrak has also become the first bispecific T cell engager to be FDA-approved for the treatment of a solid tumor. As such, unresectable or metastatic uveal melanoma usually has a poor prognosis and until the approval of Kimmtrak, there was no approved treatment.

FDA Approval 83

FDA Approval Licensing Licensing Containment 83

The Pharma Data

DECEMBER 12, 2020

Food and Drug Administration approved Pfizer’s coronavirus vaccine for emergency use on Friday, clearing the way for the launch of a national campaign to inoculate enough Americans to stem the spread of COVID-19. The nursing home industry applauded the approval. SATURDAY, Dec.

FDA Approval 52

FDA Approval Nurses Containment Doctors 52

The Pharma Data

NOVEMBER 29, 2021

Food and Drug Administration today approved Cytalux (pafolacianine), an imaging drug intended to assist surgeons in identifying ovarian cancer lesions. deputy director of the Office of Specialty Medicine in the FDA’s Center for Drug Evaluation and Research. “By The U.S.

Cosmetics 52

Cosmetics FDA Approval Protein Containment 52

XTalks

DECEMBER 26, 2022

has obtained US Food and Drug Administration (FDA) approval of an expanded indication for the use of Cytalux (pafolacianine) for the detection of lung cancer during surgery. On Target Laboratories, Inc.

Containment 52

Containment FDA Approval Development Medicine 52

The Pharma Data

AUGUST 10, 2020

The FDA has approved Olinvyk for the management of moderate to severe pain in adult patients when their pain is severe enough to require an intravenous opioid or if alternative treatments do not work.

FDA Approval 52

FDA Approval Containment Drugs Trials 52

Delveinsight

AUGUST 17, 2021

FDA’s Green Flag to Keytruda and Lenvima combination by Merck and Eisai for Advanced renal cell carcinoma (RCC). The FDA approved the combination of Keytruda and Lenvima produced by Merck and Eisai, as a first-line treatment of adult patients with advanced renal cell carcinoma (RCC).

FDA Approval 83

FDA Approval Vaccination Vaccine Antibody 83

The Pharma Data

AUGUST 15, 2021

Food and Drug Administration (FDA) has approved TICOVAC (tick-borne encephalitis (TBE) vaccine) for active immunization to prevent TBE in individuals 1 year of age and older. 1 TICOVAC is the only FDA-approved vaccine to help protect U.S.

FDA Approval 52

FDA Approval Licensing Licensing Immune Response 52

Pharma Phorum

AUGUST 6, 2020

The FDA has approved GlaxoSmithKline’s multiple myeloma drug Blenrep, a first-in-class potential blockbuster that will be used in advanced disease. The post FDA approves GSK’s Blenrep for advanced multiple myeloma appeared first on.

FDA Approval 63

FDA Approval Packaging Packaging Antibody 63

Pharma Phorum

OCTOBER 31, 2022

It is the first FDA-approved treatment for Zaire ebolavirus. These mice contain the “full repertoire” of human heavy chain immunoglobulin genes and kappa light chain genes, each linked to the endogenous mouse constant regions.

Gene 52

Gene Immune Response Containment Life Science 52

The Pharma Data

MARCH 15, 2022

director of the Office of Generic Drugs in the FDA Center for Drug Evaluation and Research. This reflects the FDA’s continued efforts to increase competition and access to quality, safe, effective and affordable medicines for patients and consumers.”. The FDA, an agency within the U.S.

Generic Drugs 52

Generic Drugs Production FDA Approval Cosmetics 52

XTalks

JUNE 29, 2022

The new FDA approval gives Breyanzi (lisocabtagene maraleucel) the broadest patient eligibility of any CAR T-cell therapy in relapsed or refractory LBCL. These are expanded indications after the FDA’s first approval of Breyanzi back in February 2021.

Gene Therapy 52

Gene Therapy FDA Approval Gene Antibody 52

The Pharma Data

DECEMBER 15, 2020

FDA Approves Klisyri (tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp. Food and Drug Administration (FDA) has approved Klisyri (tirbanibulin) for the topical treatment of actinic keratosis (AK) on the face or scalp.

FDA Approval 52

FDA Approval Dermatology Production Scientist 52

The Pharma Data

JULY 8, 2021

KEYTRUDA Is Now Approved for the Treatment of Patients With Recurrent or Metastatic or Locally Advanced cSCC That Is Not Curable by Surgery or Radiation. This approval is great news for these patients and further demonstrates Merck’s commitment to the skin cancer community.

Containment 52

Containment FDA Approval Genome Genomics 52

XTalks

JANUARY 25, 2021

GlaxoSmithKline’s (GSK) ViiV Healthcare — which focuses on HIV treatments and prevention — has received approval from the US Food and Drug Administration (FDA) for its highly anticipated injectable HIV treatment.

FDA Approval 52

FDA Approval RNA Branding Containment 52

XTalks

APRIL 6, 2021

The US Food and Drug Administration (FDA) has granted approval to the world’s first non-surgical pulmonary valve to treat severe pulmonary valve regurgitation, a condition often resulting from congenital heart disease. FDA Assessment of the Harmony Pulmonary Valve.

FDA Approval 82

FDA Approval Radiology Containment Regulation 82

The Pharma Data

JANUARY 29, 2023

Approval based on KEYNOTE-091 trial, which demonstrated a clinically meaningful improvement in disease-free survival with KEYTRUDA in these patients following surgical resection and platinum-based chemotherapy versus placebo Approval marks fifth indication for KEYTRUDA-based regimens in NSCLC and 34th indication for KEYTRUDA in the US Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. In NSCLC, KEYTRUDA has five approved U.S.

HR 40

HR Genome Genomics Dermatology 40

The Pharma Data

NOVEMBER 20, 2020

FDA Approves Zokinvy (lonafarnib) for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies. With this approval, the FDA issued a Rare Pediatric Disease Priority Review Voucher (PRV) to Eiger. Food and Drug Administration (FDA).

FDA Approval 52

FDA Approval Genetics Protein Clinical Trials 52

The Pharma Data

AUGUST 17, 2021

approval of pump use for Lilly’s novel insulin is latest development designed to help people with diabetes manage blood sugar levels. and in several global markets, including Japan and the European Union, where it is also approved for use in insulin pumps.

Insulin 52

Insulin Doctors Doctor FDA Approval 52

The Pharma Data

JUNE 22, 2022

Clinical data supporting approval demonstrated non-inferior immune responses for all serotypes shared with PCV13 following a four-dose series and superior immune responses for important disease-causing shared serotype 3 and unique serotypes 22F and 33F compared to PCV13.

Immune Response 52

Immune Response Bacterium FDA Approval Containment 52

XTalks

AUGUST 18, 2020

SalivaDirect, a saliva-based COVID-19 test that was tested among players of the National Basketball Association (NBA), has been given emergency use authorization (EUA) by the US Food and Drug Administration (FDA). And now it’s getting approval.

Reagent 77

Reagent RNA FDA Approval Genome 77

The Pharma Data

JANUARY 20, 2021

FDA Approves Verquvo (vericiguat) for Heart Failure with Reduced Ejection Fraction. The Verquvo label contains a boxed warning that indicates that Verquvo should not be administered to pregnant females because it may cause fetal harm.

FDA Approval 52

FDA Approval HR Containment Production 52

Pharma Phorum

OCTOBER 10, 2022

The FDA has approved use of GlaxoSmithKline’s Boostrix (Tdap) vaccine for use during the third trimester of pregnancy, for prevention of pertussis (whooping cough) in infants younger than two months old.

Containment 52

Containment Sales FDA Approval Trials 52

The Pharma Data

OCTOBER 14, 2020

Food and Drug Administration (FDA) approved Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) for the treatment of infection caused by Zaire ebolavirus in adult and pediatric patients, including newborns of mothers who have tested positive for the infection. TARRYTOWN, N.Y.,

FDA Approval 52

FDA Approval Production Antibody Genetics 52

The Pharma Data

JULY 8, 2021

Food and Drug Administration (FDA) has approved an updated label for ADUHELM (aducanumab-avwa) injection 100 mg/mL solution. This indication is approved under accelerated approval based on reduction in amyloid beta plaques observed in patients treated with ADUHELM.

FDA Approval 52

FDA Approval Clinical Trials Clinical Trials Development 52